The Network has recently awarded the following Round 3 Research Projects and Studentships:
Research Projects:
Dr Gwenin, A rapid point of care system to manage/monitor drug treatment in therapeutically relevant mycobacterial infections
Prof O’Donnell, Development of new prothrombotic lipids for haemostatic applications
Prof Hall, Investigating the potential of the sphingosine-1-phosphate receptor 1 modulators for the treatment of psychiatric disorders.
Prof Piguet, Anti-viral activity of ProTide derivatives on human T cells
Dr Rozanowska, Novel modulators of the visual cycle for treatment of retinal degenerations
Dr Kidd, Investigating a novel therapy for Alzheimer’s disease in a mouse model of amyloid pathology
Dr Clarkson, Sensitizing to radiotherapy: ore-clinical evaluation of a novel indication for adjuvant bcl3i
Prof Dale, Establishing a screen for the WNT-STOP mitotic signalling pathway
Prof Wilkinson, Expression and activity determination of novel cloned antibiofilm peptides
Dr Westwell, Advancing analogues of a novel cFLIP inhibitor which sensitises breast cancer cells and cancer stem cells to TRAIL
Studentships:
Dr Heard, Towards the repurposing existing of topical antimicrobials by ligand complexation.
Prof Hoffmann, Repositioning histone methyltransferase inhibitors as next generation anthelmintics.
Prof Mur, Exploiting natural products from Hops (Humulus lupulus) to suppress tuberculosis.
Prof Sheldon, Manipulation of squalene synthase to limit bacterial infections.
Dr Howell, Treating Progressive Multiple Sclerosis Using A Novel Neuroprotective And Anti-Inflammatory approach.
Dr Del Sol, Companion diagnostic development guides Antibody-Drug Conjugate formulation: Implications for patient stratification and precision medicine.
Dr Cai, Combining carbon monoxide (CO)-releasing molecules with anti-VEGF therapy for triple-negative breast cancer therapy.
Prof Doak, Design and evaluation of an antibody-drug conjugate for prostate cancer treatment.
Prof Brophy, Towards validation of an immune suppressor protein from liver fluke as a drug target.
Prof Triantafilou, Peptides derived from Yersinia pestis V antigen as novel therapeutic interventions for sepsis.
Prof Doak, Mechanistic evaluation of the impact of superparamagnetic iron oxide nanoparticles conjugated with drugs (SPIONd) on intracellular signalling/homeostatic mechanisms.
Dr Creevey, Computational approaches to mining the rumen micro biome for novel antimicrobials.
Dr Gwenin, Testing a novel chemotherapy delivery system using two dinitrobenzamide mustard prodrugs.
